Qiagen scored a 100 out of 100 on the 2023-2024 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, Qiagen increases the risk of dividing employees, alienating customers and harming shareholders. The company provides a benefits package for employees which covers transgender medical procedures for covered employees and dependents, including children. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Qiagen forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. The company integrates ESG into its business practices and provides an unconscious bias training package for its associates. Qiagen supports the Equality Act, a controversial bill. The company pledged "to hit net-zero greenhouse gas (GHG) emissions by 2050". Qiagen’s CEO, Thierry Bernard, signed the CEO Action for Diversity & Inclusion pledge, which includes a commitment to promote DEI through bias education training in the workplace. For these reasons, Qiagen receives a High Risk rating.